Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
Granulocyte Macrophage-Colony Stimulating Factor Plus Interleukin-2 Plus [alpha]-interferon Plus 5-Fluorouracil in the Treatment of Metastatic Renal Cell Cancer: Induction of CD80/86+ T Cells Indicates Adverse Outcome
Journal of Immunotherapy, 06/24/09
Westermann J et al. - Clinical response rates of this cytokine-based regimen do not justify further clinical evaluation. However, the study suggests that CD80/86+ T cells might have negative regulatory function under cytokine treatment and are possibly useful as a negative predictive marker for clinical response.
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura
British Journal of Haematology, 11/25/09
Endocrine Complications after Hematopoietic Stem Cell Transplantation during Childhood and Adolescence
Journal of Korean Medical Science, 11/24/09
Factors affecting neutrophil recovery after autologous bone marrow-derived stem cell transplantation in patients with acute myeloid leukemia
Transplantation Proceedings, 11/23/09
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Waging War against Uropathogenic Escherichia coli: Winning Back the Urinary Tract
Infection and Immunity, 11/25/09
Induction With and Without Antithymocyte Globulin Combined With Cyclosporine/Tacrolimus-Based Immunosuppression in Renal Transplantation: A Meta-analysis of Randomized Controlled Trials
Transplantation Proceedings, 11/23/09
Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results
Clinical Cancer Research, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


